CompletedNot Applicable

Radiosurgery for the Treatment of Refractory Ventricular Extrasystoles and Tachycardias

Germany20 participantsStarted 2019-12-02

Plain-language summary

Patients with refractory ventricular extrasystoles or tachycardia not eligible for catheter ablation will receive single fraction stereotactic body radiation therapy (cardiac radiosurgery) with 25 Gy. Investigators initiated this study to demonstrate that in at least 70% of the patients the planned cardiac radiosurgery may be performed without any interruption or treatment related interventional events within the first 30 days after treatment.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Recurring symptomatic monomorphic ventricular tachycardia that requires ICD intervention (e.g. shock or anti-tachycardia stimulation). At least 3 episodes within the 3 months prior to inclusion or
✓. induction of symptomatic monomorphic ventricular tachycardia that requires ICD intervention (e.g. shock or anti-tachycardia stimulation). Induction triggered by ICD or during electrophysiology studies (EPS) or both, a) and b)

What they're measuring

Acute toxicity analysed by Adverse Event (AE)- and Serious Adverse Event (SAE)-reports

Timeframe: 30 days after radiosurgery

Trial details

NCT IDNCT03867747

SponsorUniversity Hospital Schleswig-Holstein

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-11-20

View on ClinicalTrials.gov More Ventricular Tachycardia trials